Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.32902 | 12 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.31152 | 13 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.31088 | 12 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.26065 | 12 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.25719 | 12 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.38516 | 13 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.34668 | 13 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.29444 | 12 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.29007 | 13 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.29842 | 12 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.29778 | 12 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.30101 | 13 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.30716 | 12 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.30525 | 13 |